Detalles de la búsqueda
1.
Concomitant genomic features stratify prognosis to patients with advanced EGFR mutant lung cancer.
Mol Carcinog;
2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38860603
2.
Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: a multicenter, retrospective real-world study.
BMC Cancer;
24(1): 107, 2024 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38238648
3.
Pemetrexed induces ROS generation and cellular senescence by attenuating TS-mediated thymidylate metabolism to reverse gefitinib resistance in NSCLC.
J Cell Mol Med;
27(14): 2032-2044, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37278440
4.
Safety, efficacy, and pharmacokinetics of SH-1028 in EGFR T790M-positive advanced non-small cell lung cancer patients: A dose-escalation phase 1 study.
Cancer;
129(10): 1513-1522, 2023 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36813747
5.
Ferroptosis in cancer therapy: a novel approach to reversing drug resistance.
Mol Cancer;
21(1): 47, 2022 02 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35151318
6.
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial.
Mol Cancer;
21(1): 4, 2022 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34980131
7.
A two-phase comprehensive NSCLC prognostic study identifies lncRNAs with significant main effect and interaction.
Mol Genet Genomics;
297(2): 591-600, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35218396
8.
RNA methyltransferase METTL3 induces intrinsic resistance to gefitinib by combining with MET to regulate PI3K/AKT pathway in lung adenocarcinoma.
J Cell Mol Med;
25(5): 2418-2425, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33491264
9.
Efficacy and acquired resistance of EGFR-TKI combined with chemotherapy as first-line treatment for Chinese patients with advanced non-small cell lung cancer in a real-world setting.
BMC Cancer;
21(1): 602, 2021 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34034713
10.
Metabolic disposition of [14 C]-abivertinib, an epidermal growth factor receptor tyrosine kinase inhibitor: Role of glutathione conjugation.
Br J Clin Pharmacol;
87(3): 1475-1485, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32959915
11.
A Novel Long Non-Coding RNA, SOX21-AS1, Indicates a Poor Prognosis and Promotes Lung Adenocarcinoma Proliferation.
Cell Physiol Biochem;
42(5): 1857-1869, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28873379
12.
Low expression of long noncoding RNA CASC2 indicates a poor prognosis and regulates cell proliferation in non-small cell lung cancer.
Tumour Biol;
37(7): 9503-10, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26790438
13.
Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer.
Tumour Biol;
36(6): 4851-9, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25636452
14.
Downregulation of MicroRNA-1 is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Clin Lab;
61(9): 1331-6, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26554254
15.
Correlation between the expression levels of miR-1 and PIK3CA in non-small-cell lung cancer and their relationship with clinical characteristics and prognosis.
Future Oncol;
10(1): 49-57, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24328409
16.
Carbonic Anhydrase IX Controls Vulnerability to Ferroptosis in Gefitinib-Resistant Lung Cancer.
Oxid Med Cell Longev;
2023: 1367938, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36760347
17.
Lowdose anlotinib combined with EGFRTKI can be used as an alternative for EGFRTKIresistant nonsmall cell lung cancer in elderly patients.
Oncol Lett;
26(2): 323, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37415629
18.
Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR-TKIs in advanced non-small cell lung cancer: A systematic review and network meta-analysis.
Thorac Cancer;
14(6): 535-543, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36594109
19.
Efficacy and Safety of Anti-Programmed Death-Ligand 1 Monoclonal Antibody Socazolimab With Carboplatin and Etoposide for Extensive-Stage SCLC: Results From the Phase 1b Clinical Trial.
JTO Clin Res Rep;
4(4): 100478, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37020926
20.
LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer.
Cell Death Dis;
14(5): 312, 2023 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37156816